How to Use Free Wilson Analysis

Free Wilson Analysis is a classic medicinal-chemistry method introduced by Free and Wilson in 1964 for modeling structure-activity relationships in congeneric small-molecule series with a common scaffold. The core idea is additive: the measured response of each analog is approximated as the sum of contributions from substituents at defined attachment positions, which makes the method useful when scientists want interpretable R-group SAR rather than an opaque score.

On Neurosnap, researchers provide a Core Molecule that must be present in every analog and then submit Input Molecules with measured activity values such as pIC50. The workflow is well suited to scaffold-focused lead optimization, matched-series analysis, and prioritization of unsynthesized analogs assembled from already observed substituents.

The output is designed for scientific interpretation. Researchers can inspect R-group assignments, one-hot descriptor tables, coefficient estimates, and predicted activities to see which attachment points and substituents are worth pursuing next.

Free Wilson analysis first represents each compound as binary indicators for which substituent is present at each R-group position. In the Practical Cheminformatics implementation linked here, that descriptor matrix is fit with ridge regression, producing an intercept and per-substituent coefficients that estimate whether a specific R-group tends to raise or lower the activity endpoint.

On Neurosnap, the series is aligned to the supplied core, converted into an R-group descriptor matrix, and summarized through coefficient tables, descriptor exports, and predicted activities for enumerated products that were not synthesized in the original set. This is most appropriate when compounds genuinely form a congeneric series around one scaffold and when SAR is driven mainly by substituent changes rather than scaffold hops or strongly nonadditive effects.

For scientists, the main value is interpretability. Free Wilson analysis helps rationalize attachment-point trends, compare favorable and unfavorable substituents, and prioritize the next analogs to make from combinations already supported by the observed chemistry.

• Shared-scaffold analysis: Requiring a common core keeps the workflow aligned with real congeneric medicinal-chemistry series.
• Interpretable substituent effects: Additive R-group coefficients make it clear which attachment points and substituents improve or weaken the measured activity.
• Enumeration of next analogs: The model can score unsynthesized combinations of observed substituents instead of only summarizing the compounds already made.
• Practical export tables: R-group assignments, one-hot descriptors, coefficients, and predictions can be taken directly into downstream SAR review.